The time course and the phenomenology of the initial response to clomipramine (10-20 mg/day) was investigated in 70 patients with panic disorder with or without agoraphobia. Nineteen (27.1%) patients reported worsening of their clinical state which, on average, began 28 h after the first dose and lasted for 5 days. Increase in the frequency and severity of panic attacks was the most frequent finding (14 patients), followed by psycho- stimulant (jitteriness; n=9), depressive (n=8) and tonic anxiety symptoms (n=7). This pattern of initial worsening is different from the 'jitteriness syndrome' described for other antidepressants. Its implications for the understanding of the pathophysiology of panic disorder are discussed.
Aronson T.A. (1987) A naturalistic study of imipramine in panic disorder and agoraphobia. Am J Psychiatr144: 1014-1019
2.
Brewerton T.D. (1991) Does fluoxetine induce suicidality? (letter). J Clin Psychiatr52: 479
3.
Caetano D. (1985) Tratamento da desordem do pânico com clomipramina. Estudo aberto de 22 casos. J Bras Psiq34: 123-132
4.
Cazzullo C.L. (1969) Drug treatment of anxiety. In Lader M H (ed.), Studies of anxiety. Br J Psychiatry Special Publication 3, World Psychiatric Association , Headley Bros, Ashford, pp. 109-121
5.
Charney D.S., Heninger G.R. (1986) Abnormal regulation of noradrenergic function in panic disorders. Arch Gen Psychiatr43: 1042-1054
6.
Clark D.M. (1986) A cognitive approach to panic. Behav Res Ther24: 461-470
7.
Damluji N.F., Ferguson J.M. (1988) Paradoxical worsening of depressive symptomatology caused by antidepressants. J Clin Psychopharmacol8: 347-349
8.
Deakin J F W, Graeff F.G. (1991) 5HT and mechanisms of defence. J Psychopharmacol5: 305-315
9.
Fava M., Rosenbaum J.F. (1991) Suicidality and fluoxetine: is there a relationship ? J Clin Psychiatr52: 108-111
Gentil V. (1985) Ataques de panico: resposta terapêutica. In Gentil V (ed.), Ansiedade autonômica: diagnóstico diferencial e bases biológicas. Fontoura-Wyeth , São Paulo, vol 3, pp. 14-17
12.
Gentil V. (1986) Mecanismo de ação de drogas antipânico. J Bras Psiq35: 155-162
13.
Gentil V. (1988) Towards an integrated model for panic disorder (Guest Editorial). Stress Med4: 131-133
14.
Gloger S., Grunhaus L., Birmacher B., Troudart T. (1981) Treatment of spontaneous panic attacks with clomipramine . Am J Psychiatr138: 1215-1217
15.
Gorman J.M., Liebowitz M.R., Fyer A.J., Goetz D., Campeas B., Fyer M.R., Davies S.O., Klein D.F. (1987) An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol7: 329-332
16.
Johnston D.G., Troyer I.E., Whitsett S.F. (1988) Clomipramine treatment of agoraphobic women. Arch Gen Psychiatr45: 453-459
17.
Kahn R.S., Westenberg H G M, Verhoeven W M A, Wied C C G, Kamerbeek W.D. (1987) Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double blind comparison of 5-hydroxytryptophan, clomipramine, and placebo. Int Clin Psychopharmacol2: 33-45
18.
Kahn R.S., Van Praag H.M., Wetzler S., Asnis G.M., Barr G. ( 1988a) Serotonin and anxiety revisited. Biol Psychiatr23: 189-208
19.
Kahn R.S., Van Praag H.M., Asnis G.M., Strauman T. (1988b) Behavioral indications of serotonin receptor hypersensitivity in panic disorder. Psychiatr Res25: 101-104
20.
Levinson H.N. (1989) The cerebellar-vestibular predisposition to anxiety disorders. Percept Motor Skills68: 323-338
21.
Lydiard R.B., Jackson C.W. (1991) Reply to Dr. Friedman (letter). J Clin Psychopharmacol11 : 395
22.
Marks I. (1983) Are there anticompulsive or antiphobic drugs? Review of the evidence. Br J Psychiatr143: 338-347
23.
Mavissakalian M., Perel J. (1985) Imipramine in the treatment of agoraphobia: dose-response relationships. Am J Psychiatr142: 1032-1036
24.
Mavissakalian M., Perel J., Bowler K., Dealy R. (1987) Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. Am J Psychiatr144: 785-787
25.
Modigh K., Westberg P., Eriksson E. (1992) Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial. J Clin Psychopharmacol12 : 251-261
26.
Noyes R., Garvey M.J., Cook B.L., Samuelson L. (1989) Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study . J Clin Psychiatr50: 163-169
27.
Nutt D.J. (1989) Altered central alpha-2 adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatr46: 165-169
28.
Pohl R., Yeragani V.K., Balon R., Lycaki H. (1988) The jitteriness syndrome in panic patients treated with antidepressants. J Clin Psychiatr49: 100-104
29.
Soloff P.H., George A., Nathan R.S., Schulz P.M., Perel J.M. (1986) Paradoxical effects of amitriptyline on borderline patients. Am J Psychiatr143: 1603-1605
30.
Targum S.D., Marshall L.E. (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatr Res28: 295-306
31.
Teicher M.H., Glod C., Cole J.O. (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatr147: 207-210
32.
Telch M.J., Tearnan B.H., Taylor C.B. (1983) Antidepressant medication in the treatment of agoraphobia: a critical review. Behav Res Ther21: 505-517
33.
Zitrin C.M., Klein D.F., Woerner M.G. (1978) Behavior therapy, supportive psychotherapy, imipramine, and phobias. Arch Gen Psychiatr35: 307-316
